Date:June 22, 2026

Great to connect with Dr. Delese Mimi Darko, Director General of the African Medicines Agency (AMA), and Senior Advisor Prof. Alex Dodoo this week.
We commend AMA’s progress in strengthening regulatory alignment across Africa – critical as patients continue to face substandard and falsified medicines. Strong oversight is essential to protect public health.
Equally important is building a consistent supply chain of quality, affordable medicines through strengthened local manufacturing, production, and distribution of essential, locally produced products.
Bio Usawa stands ready to work alongside AMA, national regulatory authorities, and committed partners to help unlock Africa’s full biotech potential. The opportunity – and responsibility – is clear: together, we can transform access to safe, high-quality medicines.
We call on stakeholders across sectors to step forward and collaborate now to turn this vision into reality.

This week, Bio Usawa’s Chief Operating Officer and Chief Regulatory Officer, Dr. Patrick Lukulay, paid a courtesy visit to Prof. Emile Bienvenu, Directo…
July 2026Bio Usawa executives recently engaged with the Rwanda Ministry of Health (MoH), the Ministry of Education, and various stakeholders in a productive cons…
July 2026At the Grand Challenges Annual Meeting 2026 in London, a clear and urgent theme emerged: Africa’s future in biotechnology will be defined not by a short…
June 2026